{"disease":{"id":"double-expressor-lymphoma-del","name":"double expressor lymphoma del"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06891157","title":"Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":148,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}